| European Medicines Agency - Eligible Group Status - COMP [Committee for Orphan Medicinal Products] - SAWP [Scientific Advice Working Party]. | Respiratorio
> Fibrosis pulmonar | Asociación regulatoria
> Trabajando con organismos reguladores | Not specified | International | Rarely | 119039359117 |
| When new drugs are approved by the EU medicines agency, we work to represent patient interest with the health service and government agency responsible for approving the drug in Ireland and regulating pricing of new drugs. | Respiratorio
> Enfermedades Pulmonares Intersticiales (EPI) | Asociación regulatoria
> Trabajando con organismos reguladores | 5000 | National | Sometimes | 119044171823 |
| Submission on Lutathera for reimbursement decision. | Cáncer
> Cáncer: neuroendocrino (NET) | Asociación regulatoria
> Participar en evaluaciones de Evaluación de Tecnologías Sanitarias (ETS) y reembolso | 1000 | National | Rarely | 119039308095 |
| We share the patient experience of living with a condition as part of the reimbursement process. | Neuromuscular
> Enfermedades neuromusculares: la mayoría de los tipos | Asociación regulatoria
> Participar en evaluaciones de Evaluación de Tecnologías Sanitarias (ETS) y reembolso | 1000 | National | Sometimes | 119047368493 |
| We submitted our support to the NCPE [National Centre for Pharmacoeconomics] for their appraisal of Lutathera [used to treat adults with certain unresectable or metastatic gastroenteropancreatic neuroendocrine tumors]. | Cáncer
> Cáncer: neuroendocrino (NET) | Asociación regulatoria
> Participar en evaluaciones de Evaluación de Tecnologías Sanitarias (ETS) y reembolso | 100 | National | Rarely | 119051190597 |
| Drugs for ataxia are very rare, so we only make submissions as they become available. | Neurodegenerativo
> Ataxia | Asociación regulatoria
> Contribuir a las presentaciones de Autorización de Comercialización | 1000 | National | Rarely | 119020208311 |
| European Medicines Agency - Eligible Group Status - COMP [Committee for Orphan Medicinal Products] - SAWP [Scientific Advice Working Party]. | Respiratorio
> Fibrosis pulmonar | Asociación regulatoria
> Asistir/facilitar reuniones con responsables políticos/reguladores | Not specified | International | Rarely | 119039359117 |
| Meetings with Government Representatives and Department of Health regarding the availability of certain DMTs [Disease-Modifying Therapies primarily used for multiple sclerosis and various autoimmune conditions (like rheumatoid arthritis)]. | Neurológico
> Esclerosis múltiple | Asociación regulatoria
> Asistir/facilitar reuniones con responsables políticos/reguladores | 10.000 | National | Regularly | 119074666617 |
| National organization is affiliated with European groups which attempt to have influence. | Salud general
> Alfabetización en salud | Asociación regulatoria
> Con otros defensores de la salud | 100 | National | Rarely | 119052876993 |
| Advocacy/public affairs messaging about improving reimbursement decision-making for drugs in Ireland. | Cáncer
> Cáncer: la mayoría de los tipos | Impactando en políticas y legislación
> Influir en la política sanitaria y la legislación | 10.000 | National | Rarely | 119063937918 |
| We have advocated for our members to our government representatives at yearly events where we have been invited to government buildings to present to an invited group. | Defensa del paciente
> Activista de salud | Impactando en políticas y legislación
> Participar en audiencias públicas y consultas | 5000 | National | Rarely | 119047297038 |
| We have advocated for our members to our government representatives at yearly events where we have been invited to government buildings to present to an invited group. | Defensa del paciente
> Activista de salud | Impactando en políticas y legislación
> Movilizar parlamentarios y líderes políticos | 5000 | National | Rarely | 119047297038 |
| We advocate for the most efficient medicine to be available and reimbursed for heart failure patients. | Corazón
> Insuficiencia cardíaca | Impactando en políticas y legislación
> Abordando barreras/anomalías en la atención médica | 5000 | National | Sometimes | 119051411038 |
| When new drugs are approved by the EU medicines agency, we work to represent patient interest with the health service and government agency responsible for approving the drug in Ireland and regulating pricing of new drugs. | Respiratorio
> Enfermedades Pulmonares Intersticiales (EPI) | Defensa de precios y asequibilidad
> Participar en negociaciones con el comité de revisión de precios | 5000 | National | Sometimes | 119044171823 |
| Advocacy/public affairs messaging about improving reimbursement decision-making for drugs in Ireland. | Cáncer
> Cáncer: la mayoría de los tipos | Defensa de precios y asequibilidad
> Abogando por la inclusión del producto en listas de reembolso/formularios nacionales | 10.000 | National | Rarely | 119063937918 |
| Equity of access: Public patients can wait a lot longer for access to meds approved by EMA [European Medicines Agency], versus private patients whose insurance companies reimburse. | Defensa del paciente
> Activista de salud | Mejora de las vías de acceso
> Facilitar el acceso equitativo a medicamentos/atención sanitaria | 1000 | National | Sometimes | 119044976833 |
| We advocate for the most efficient medicine to be available and reimbursed for heart failure patients. | Corazón
> Insuficiencia cardíaca | Mejora de las vías de acceso
> Facilitar el acceso equitativo a medicamentos/atención sanitaria | 5000 | National | Sometimes | 119051411038 |
| Meetings with Government Representatives and Department of Health regarding the availability of certain DMTs [Disease-Modifying Therapies primarily used for multiple sclerosis and various autoimmune conditions (like rheumatoid arthritis)]. | Neurológico
> Esclerosis múltiple | Mejora de las vías de acceso
> Facilitar el acceso equitativo a medicamentos/atención sanitaria | 10.000 | National | Regularly | 119074666617 |
| Equity of access: Public patients can wait a lot longer for access to meds approved by EMA [European Medicines Agency], versus private patients whose insurance companies reimburse. | Defensa del paciente
> Activista de salud | Mejora de las vías de acceso
> Abordar las disparidades en el acceso y la gestión | 1000 | National | Sometimes | 119044976833 |
| Drugs for ataxia are very rare, so we only make submissions as they become available. | Neurodegenerativo
> Ataxia | Mejora de las vías de acceso
> Mejora del acceso a terapias raras/ultrararas | 1000 | National | Rarely | 119020208311 |
| During the course of projects based on issues experienced by the community. | Gastrointestinal
> IBD | Aportaciones del paciente basadas en evidencia
> Aprovechar las historias de pacientes y los relatos de experiencias vividas | 5000 | National | Sometimes | 119020296590 |
| We share the patient experience of living with a condition as part of the reimbursement process. | Neuromuscular
> Enfermedades neuromusculares: la mayoría de los tipos | Aportaciones del paciente basadas en evidencia
> Aprovechar las historias de pacientes y los relatos de experiencias vividas | 1000 | National | Sometimes | 119047368493 |